Login / Signup

TFAP2A Activates S100A2 to Mediate Glutamine Metabolism and Promote Lung Adenocarcinoma Metastasis.

Tao ZengWangsheng RenHang ZengDachun WangXianyu WuGuo Xu
Published in: The clinical respiratory journal (2024)
In conclusion, by regulating glutamine metabolism, the TFAP2A/S100A2 axis facilitated LUAD metastasis. This suggested that targeting S100A2 could be beneficial for LUAD treatment.
Keyphrases
  • combination therapy
  • replacement therapy